These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20638585

  • 1. First- and second-trimester screening for preeclampsia and intrauterine growth restriction.
    Tuuli MG, Odibo AO.
    Clin Lab Med; 2010 Sep; 30(3):727-46. PubMed ID: 20638585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, Cuckle H, Wolf M.
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers.
    Pilalis A, Souka AP, Antsaklis P, Basayiannis K, Benardis P, Haidopoulos D, Papantoniou N, Mesogitis S, Antsaklis A.
    Acta Obstet Gynecol Scand; 2007 Jul; 86(5):530-4. PubMed ID: 17464579
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, FASTER Trial Research Consortium.
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [Abstract] [Full Text] [Related]

  • 11. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T, Hoffman B, Meschino W, Kingdom J, Okun N.
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [Abstract] [Full Text] [Related]

  • 12. Uterine artery Doppler in first-trimester pregnancy screening.
    Bahado-Singh RO, Jodicke C.
    Clin Obstet Gynecol; 2010 Dec; 53(4):879-87. PubMed ID: 21048455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction between risk factors for fetal growth retardation associated with abnormal umbilical artery Doppler studies.
    Spinillo A, Bergante C, Gardella B, Mainini R, Montanari L.
    Acta Obstet Gynecol Scand; 2004 May; 83(5):431-5. PubMed ID: 15059153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.